The pharmaceutical landscape is experiencing a change with the emergence of GLP-1 transdermal systems . These innovative formulations offer a promising alternative to providing glucagon-like peptide-1 drugs for individuals living with hyperglycemia. Instead of daily shots , a convenient patch placed to the area could release a steady amount of the